Sanofi (SNYNF)

Market Cap	117.29B
Revenue (ttm)	48.82B
Net Income (ttm)	6.81B
Shares Out	n/a
EPS (ttm)	5.45
PE Ratio	17.23
Forward PE	9.97
Dividend	n/a
Ex-Dividend Date	n/a

Volume	208
Average Volume	44,283
Open	97.39
Previous Close	94.23
Day's Range	97.39 - 97.39
52-Week Range	91.81 - 122.03
Beta	0.41
RSI	45.87
Earnings Date	Jul 31, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 82,878
• Stock Exchange: OTCMKTS
• Ticker Symbol: SNYNF

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial numbers in EUR